Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00228839
Recruitment Status : Completed
First Posted : September 29, 2005
Last Update Posted : June 30, 2009
Sponsor:
Information provided by:
Emory University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Primary Completion Date : No date given
Actual Study Completion Date : October 2006